Immune checkpoint inhibitor medications: A game-changer in cancer treatments
A report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.
Read More
Employer expectations for cancer care in 2025
Rise in cancer incidence, technological advancements and health care costs will have a significant impact on health outcomes and employers’ bottom line.
Read More
Easing the impact of GLP-1s
With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.
Read More
Express Scripts in 2023: Supporting clients, patients, and health plans
Over the last 12 months, Express Scripts has rolled out numerous groundbreaking programs and projects. Learn about some of the most notable advancements and innovations of 2023.
Read More
Preparing the market for the evolving biosimilar landscape
With more biosimilars and the first major influx of interchangeable inflammatory biosimilars coming to market, proactive education and outreach will be crucial for successful conversions to low-cost o...
Read More
The future of health care is connected, accessible, value-based, and enabled by technology
During the Reuters Total Health conference, Evernorth Health Services leaders reflected on some of health care’s biggest challenges and explored opportunities to improve connectivity, access, and outc...
Read More